| 1 | CD14, CD33, TLR4 |
| Negative regulation of Toll-like receptor-4 signaling through the binding of glycosylphosphatidylinositol-anchored glycoprotein, CD14, with the sialic acid-binding lectin, CD33. | |
| Ishida A, Akita K, Mori Y, Tanida S, Toda M, Inoue M, Nakada H. | |
| J Biol Chem 289(36):25341-50. doi: 10.1074/jbc.M113.523480. Epub 2014 Jul 24. 2014 | |
| 2 | ABCA7, CD2AP, CD33 |
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. | |
| Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Rüther E, Schürmann B, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Gallacher J, Hüll M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC; Alzheimer's Disease Neuroimaging Initiative, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S; CHARGE consortium, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alpérovitch A, Lathrop M; EADI1 consortium, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossů P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J. | |
| Nat Genet 43(5):429-35. Epub 2011 Apr 3. 2011 | |
| 3 | CD33 |
| IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33+ myeloma cells. | |
| Shamsasenjan K, Otsuyama K, Abroun S, Iqbal MS, Mahmoud MS, Asaoku H, Kawano MM. | |
| Int J Hematol 89(3):310-8. Epub 2009 Mar 4.PMID: 19259613 2009 | |
| 4 | CD33 |
| CD33+ CD14- phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone. | |
| Forsyth RG, De Boeck G, Baelde JJ, Taminiau AH, Uyttendaele D, Roels H, Praet MM, Hogendoorn PC. | |
| J Bone Miner Res 24(1):70-7.PMID: 18767926 2009 | |
| 5 | CD33 |
| Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor. | |
| Walter RB, Häusermann P, Raden BW, Teckchandani AM, Kamikura DM, Bernstein ID, Cooper JA. | |
| Traffic 9(2):267-79. Epub 2007 Dec 18.PMID: 18062779 2008 | |
| 6 | CD33 |
| A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing. | |
| Hernández-Caselles T, Martínez-Esparza M, Pérez-Oliva AB, Quintanilla-Cecconi AM, García-Alonso A, Alvarez-López DM, García-Peńarrubia P. | |
| J Leukoc Biol 79(1):46-58.PMID: 16380601 2006 | |
| 7 | CD33 |
| Role of protein kinase C in the phosphorylation of CD33 (Siglec-3) and its effect on lectin activity. | |
| Grobe K, Powell LD. | |
| Blood 99(9):3188-96. 2002 | |
| 8 | CD33, SIGLEC12, SIGLEC5, SIGLEC7, SIGLECP1 |
| Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes. | |
| Yousef GM, Ordon MH, Foussias G, Diamandis EP. | |
| Gene 286(2):259-70. 2002 | |
| 9 | CD33 |
| The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. | |
| Ulyanova T, Blasioli J, Woodford-Thomas TA, Thomas ML. | |
| Eur J Immunol 29(11):3440-9 1999 | |
| 10 | CD33, SIGLEC6 |
| Molecular cloning of a novel gene similar to myeloid antigen CD33 and its specific expression in placenta. | |
| Takei Y, Sasaki S, Fujiwara T, Takahashi E, Muto T, Nakamura Y. | |
| Cytogenet Cell Genet 78(3-4):295-300. 1997 | |
| 11 | SIGLEC1, CD22, CD33, MAG |
| Sialoadhesin (Sn) maps to mouse chromosome 2 and human chromosome 20 and is not linked to the other members of the sialoadhesin family, CD22, MAG and CD33. | |
| Mucklow S, et al. | |
| Genomics 28 : 344-346. 1995 | |
| 12 | CD33 |
| Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. | |
| Freeman SD, et al. | |
| Blood 85 : 2005-2012. 1995 | |
| 13 | CD33 |
| Expression of the myeloid differentiation antigene CD33 depends on the presence of human chromosome 19 in human-mouse hybrids. | |
| Adriaansen HJ, et al. | |
| Ann Hum Genet 54 : 115-119. 1990 | |
| 14 | CD33 |
| Molecular cloning, expression, and chromosomal localization of a human gene encoding the CD33 myeloid differentiation antigen. | |
| Peiper SC, et al. | |
| Blood 72 : 314-321. 1988 | |